{
  "doc_id": "8f553fb846eaa975e1e09e0a83ac592c3a24f11e20ba44e4635f02e5ed3c9427",
  "chunk_entities": [
    {
      "chunk_id": "8fc496eafb26889796e8a92e9af68a26",
      "entities": [
        {
          "entity_type": "Compound",
          "entity_name": "mesembrine",
          "context": "High-mesembrine Sceletium extract"
        },
        {
          "entity_type": "Compound",
          "entity_name": "serotonin",
          "context": "selective serotonin reuptake inhibitor"
        },
        {
          "entity_type": "Plant",
          "entity_name": "Sceletium spp.",
          "context": "Sceletium extract"
        },
        {
          "entity_type": "Effect",
          "entity_name": "monoamine releasing agent",
          "context": "is a monoamine releasing agent"
        },
        {
          "entity_type": "Effect",
          "entity_name": "selective serotonin reuptake inhibitor",
          "context": "a selective serotonin reuptake inhibitor"
        }
      ]
    },
    {
      "chunk_id": "2bec7cab4b9f089af0a036526bf28230",
      "entities": [
        {
          "entity_type": "Compound",
          "entity_name": "alkaloids",
          "context": "alkaloids contained in plants"
        },
        {
          "entity_type": "Plant",
          "entity_name": "Sceletium",
          "context": "plants in the genus Sceletium"
        },
        {
          "entity_type": "Compound",
          "entity_name": "ligand",
          "context": "inhibit ligand binding"
        },
        {
          "entity_type": "Compound",
          "entity_name": "serotonin",
          "context": "serotonin transporter"
        },
        {
          "entity_type": "Effect",
          "entity_name": "inhibit ligand binding",
          "context": "reported to inhibit ligand binding"
        },
        {
          "entity_type": "Effect",
          "entity_name": "selective serotonin-reuptake inhibitors",
          "context": "act as selective serotonin-reuptake inhibitors"
        },
        {
          "entity_type": "Effect",
          "entity_name": "anxiolytic",
          "context": "anxiolytic or anti-depressant effect"
        },
        {
          "entity_type": "Effect",
          "entity_name": "anti-depressant",
          "context": "anxiolytic or anti-depressant effect"
        },
        {
          "entity_type": "Compound",
          "entity_name": "monoamine",
          "context": "such as monoamine release"
        },
        {
          "entity_type": "Effect",
          "entity_name": "monoamine release",
          "context": "such as monoamine release"
        }
      ]
    },
    {
      "chunk_id": "8ff6dbea3e13cf813638f8475d442d67",
      "entities": [
        {
          "entity_type": "Effect",
          "entity_name": "anxiolytic effects",
          "context": "evidence for anxiolytic effects of Sceletium products"
        },
        {
          "entity_type": "Plant",
          "entity_name": "Sceletium",
          "context": "anxiolytic effects of Sceletium products"
        },
        {
          "entity_type": "Disease",
          "entity_name": "restraint-induced stress",
          "context": "rat model of restraint-induced stress"
        },
        {
          "entity_type": "Compound",
          "entity_name": "serotonin",
          "context": "inhibit serotonin binding"
        },
        {
          "entity_type": "Compound",
          "entity_name": "serotonin transporter",
          "context": "serotonin binding to the serotonin transporter"
        },
        {
          "entity_type": "Compound",
          "entity_name": "alkaloids",
          "context": "some of the alkaloids contained in Sceletium"
        },
        {
          "entity_type": "Plant",
          "entity_name": "Sceletium",
          "context": "alkaloids contained in Sceletium"
        },
        {
          "entity_type": "Compound",
          "entity_name": "phosphodiesterase 4A",
          "context": "inhibit phosphodiesterase 4A activity"
        },
        {
          "entity_type": "Compound",
          "entity_name": "mesembrenone",
          "context": "potency: mesembrenone"
        },
        {
          "entity_type": "Compound",
          "entity_name": "mesembrine",
          "context": "mesembrenone > mesembrine"
        },
        {
          "entity_type": "Compound",
          "entity_name": "mesembrenol",
          "context": "mesembrine > mesembrenol"
        },
        {
          "entity_type": "Plant",
          "entity_name": "Sceletium",
          "context": "Sceletium acts as selective serotonin-reuptake inhibitor"
        },
        {
          "entity_type": "Effect",
          "entity_name": "selective serotonin-reuptake inhibitor",
          "context": "Sceletium acts as selective serotonin-reuptake inhibitor"
        },
        {
          "entity_type": "Effect",
          "entity_name": "anxiolytic",
          "context": "result in the anxiolytic"
        },
        {
          "entity_type": "Effect",
          "entity_name": "anti-",
          "context": "or anti-"
        }
      ]
    },
    {
      "chunk_id": "469c22959d9e2581b3e225a67aeb4fb6",
      "entities": [
        {
          "entity_type": "Effect",
          "entity_name": "depressant effect",
          "context": "depressant effect ascribed to Sceletium"
        },
        {
          "entity_type": "Plant",
          "entity_name": "Sceletium",
          "context": "depressant effect ascribed to Sceletium"
        },
        {
          "entity_type": "Compound",
          "entity_name": "monoamine",
          "context": "such as monoamine release"
        },
        {
          "entity_type": "Effect",
          "entity_name": "monoamine release",
          "context": "such as monoamine release"
        },
        {
          "entity_type": "Compound",
          "entity_name": "SSRIs",
          "context": "administration of SSRIs"
        },
        {
          "entity_type": "Effect",
          "entity_name": "up-regulation of PDE4",
          "context": "linked to up-regulation of PDE4"
        },
        {
          "entity_type": "Compound",
          "entity_name": "PDE4",
          "context": "up-regulation of PDE4"
        },
        {
          "entity_type": "Effect",
          "entity_name": "hypersensitivity to SSRIs",
          "context": "subsequent hypersensitivity to SSRIs"
        },
        {
          "entity_type": "Effect",
          "entity_name": "decreased PDE4 activity",
          "context": "report of decreased PDE4 activity"
        },
        {
          "entity_type": "Plant",
          "entity_name": "Sceletium",
          "context": "with Sceletium administration"
        },
        {
          "entity_type": "Compound",
          "entity_name": "SSRI",
          "context": "being a pure SSRI"
        }
      ]
    },
    {
      "chunk_id": "1e8b2fb77485c748b20c4586f8a185f7",
      "entities": [
        {
          "entity_type": "Compound",
          "entity_name": "Dulbecco's Modified Eagles medium (DMEM)",
          "context": "supplemented with Dulbecco's Modified Eagles medium (DMEM)"
        },
        {
          "entity_type": "Compound",
          "entity_name": "foetal bovine serum (FBS)",
          "context": "10% foetal bovine serum (FBS)"
        },
        {
          "entity_type": "Compound",
          "entity_name": "GA-1000",
          "context": "1% GA-1000"
        },
        {
          "entity_type": "Compound",
          "entity_name": "CO2",
          "context": "presence of 5% CO2"
        },
        {
          "entity_type": "Compound",
          "entity_name": "serotonin",
          "context": "serotonin release and serotonin reuptake inhibition"
        },
        {
          "entity_type": "Effect",
          "entity_name": "viability testing",
          "context": "for viability testing"
        },
        {
          "entity_type": "Effect",
          "entity_name": "serotonin release",
          "context": "assessments related to serotonin release"
        },
        {
          "entity_type": "Effect",
          "entity_name": "serotonin reuptake inhibition",
          "context": "serotonin reuptake inhibition"
        },
        {
          "entity_type": "Dosage",
          "entity_name": "10%",
          "context": "10% foetal bovine serum (FBS)"
        },
        {
          "entity_type": "Dosage",
          "entity_name": "1%",
          "context": "1% GA-1000"
        },
        {
          "entity_type": "Dosage",
          "entity_name": "5%",
          "context": "presence of 5% CO2"
        },
        {
          "entity_type": "Dosage",
          "entity_name": "37 \u00b0C",
          "context": "at 37 \u00b0C"
        },
        {
          "entity_type": "Dosage",
          "entity_name": "80%",
          "context": "At 80% confluence"
        },
        {
          "entity_type": "Dosage",
          "entity_name": "7.5 \u00d7 10^4",
          "context": "7.5 \u00d7 104 astrocytes"
        },
        {
          "entity_type": "Dosage",
          "entity_name": "1 \u00d7 10^6",
          "context": "1 \u00d7 106 GT1-7 cells per well"
        },
        {
          "entity_type": "Dosage",
          "entity_name": "8 \u00d7 10^4",
          "context": "8 \u00d7 104 astrocytes"
        },
        {
          "entity_type": "Dosage",
          "entity_name": "1 \u00d7 10^5",
          "context": "1 \u00d7 105 GT1-7 cells"
        }
      ]
    },
    {
      "chunk_id": "74396405fe328148db132ca64801f5a7",
      "entities": [
        {
          "entity_type": "Compound",
          "entity_name": "alkaloids",
          "context": "percentage of various alkaloids"
        },
        {
          "entity_type": "Compound",
          "entity_name": "\u03947-mesembranone",
          "context": "\u03947-mesembranone at approximately 2.1 minutes"
        },
        {
          "entity_type": "Compound",
          "entity_name": "mesembranone",
          "context": "mesembranone at approximately 3.1 minutes"
        },
        {
          "entity_type": "Compound",
          "entity_name": "mesembrine",
          "context": "mesembrine at approximately 4.1 minutes"
        }
      ]
    },
    {
      "chunk_id": "340c7c12c3ee26c806be72103ce925cd",
      "entities": [
        {
          "entity_type": "Compound",
          "entity_name": "mesembrine",
          "context": "high-mesembrine Sceletium extract"
        },
        {
          "entity_type": "Plant",
          "entity_name": "Sceletium",
          "context": "high-mesembrine Sceletium extract"
        },
        {
          "entity_type": "Dosage",
          "entity_name": "1 mg/ml",
          "context": "extract (TRI, 1 mg/ml"
        },
        {
          "entity_type": "Dosage",
          "entity_name": "0.1 mg/ml",
          "context": "1 mg/ml, 0.1 mg/ml"
        },
        {
          "entity_type": "Dosage",
          "entity_name": "0.01 mg/ml",
          "context": "0.1 mg/ml, 0.01 mg/ml"
        },
        {
          "entity_type": "Dosage",
          "entity_name": "0.001 mg/ml",
          "context": "0.01 mg/ml, 0.001 mg/ml"
        },
        {
          "entity_type": "Dosage",
          "entity_name": "0.0001 mg/ml",
          "context": "0.001 mg/ml and 0.0001 mg/ml"
        },
        {
          "entity_type": "Compound",
          "entity_name": "DMEM",
          "context": "dissolving it in DMEM"
        },
        {
          "entity_type": "Dosage",
          "entity_name": "24 h",
          "context": "for a period of 24 h"
        },
        {
          "entity_type": "Effect",
          "entity_name": "mitochondrial viability",
          "context": "mitochondrial viability was assessed"
        },
        {
          "entity_type": "Compound",
          "entity_name": "MTT",
          "context": "using the MTT assay"
        },
        {
          "entity_type": "Effect",
          "entity_name": "neurophysiological effects",
          "context": "assessment of neurophysiological effects"
        },
        {
          "entity_type": "Dosage",
          "entity_name": "15 min",
          "context": "treatment for 15 as well as 30-min"
        },
        {
          "entity_type": "Dosage",
          "entity_name": "30-min",
          "context": "15 as well as 30-min"
        }
      ]
    },
    {
      "chunk_id": "bbe6b936d4e97f3489235066c0117442",
      "entities": [
        {
          "entity_type": "Plant",
          "entity_name": "Sceletium",
          "context": "Sceletium extract"
        },
        {
          "entity_type": "Compound",
          "entity_name": "Sceletium extract",
          "context": "exposure to Sceletium extract"
        },
        {
          "entity_type": "Compound",
          "entity_name": "Citalopram",
          "context": "10 \u00b5M Citalopram"
        },
        {
          "entity_type": "Dosage",
          "entity_name": "10 \u00b5M",
          "context": "10 \u00b5M Citalopram"
        },
        {
          "entity_type": "Compound",
          "entity_name": "paraformaldehyde",
          "context": "using 4% paraformaldehyde"
        },
        {
          "entity_type": "Dosage",
          "entity_name": "4%",
          "context": "4% paraformaldehyde"
        },
        {
          "entity_type": "Compound",
          "entity_name": "phosphate buffer solution",
          "context": "phosphate buffer solution (PBS)"
        },
        {
          "entity_type": "Compound",
          "entity_name": "Triton X-100",
          "context": "0.05% Triton X-100"
        },
        {
          "entity_type": "Dosage",
          "entity_name": "0.05%",
          "context": "0.05% Triton X-100"
        },
        {
          "entity_type": "Compound",
          "entity_name": "bovine serum albumin",
          "context": "1% bovine serum albumin (BSA)"
        },
        {
          "entity_type": "Dosage",
          "entity_name": "1%",
          "context": "1% bovine serum albumin"
        },
        {
          "entity_type": "Compound",
          "entity_name": "vesicular monoamine transporter 2 primary antibody",
          "context": "binding of the vesicular monoamine transporter 2 (VMAT-2) primary antibody"
        },
        {
          "entity_type": "Compound",
          "entity_name": "serotonin reuptake transporter primary antibody",
          "context": "the serotonin reuptake transporter (SERT) primary antibody"
        },
        {
          "entity_type": "Compound",
          "entity_name": "Secondary antibodies",
          "context": "Secondary antibodies used"
        }
      ]
    },
    {
      "chunk_id": "a1c5f9c1e8e47521b919b01709653d0e",
      "entities": [
        {
          "entity_type": "Compound",
          "entity_name": "Sceletium extract",
          "context": "by the Sceletium extract"
        },
        {
          "entity_type": "Plant",
          "entity_name": "Sceletium",
          "context": "reports on Sceletium"
        },
        {
          "entity_type": "Effect",
          "entity_name": "cell viability",
          "context": "cell viability was not influenced"
        },
        {
          "entity_type": "Dosage",
          "entity_name": "any dose",
          "context": "at any dose"
        }
      ]
    },
    {
      "chunk_id": "492835162c23792366537ee057b5ee0d",
      "entities": [
        {
          "entity_type": "Compound",
          "entity_name": "TRI",
          "context": "TRI 0.001"
        },
        {
          "entity_type": "Effect",
          "entity_name": "cell viability",
          "context": "24hr cell viability (%control)"
        },
        {
          "entity_type": "Effect",
          "entity_name": "viability",
          "context": "show viability around 100%"
        },
        {
          "entity_type": "Dosage",
          "entity_name": "0.001",
          "context": "TRI 0.001"
        },
        {
          "entity_type": "Dosage",
          "entity_name": "0.01",
          "context": "TRI 0.01"
        },
        {
          "entity_type": "Dosage",
          "entity_name": "0.1",
          "context": "TRI 0.1"
        },
        {
          "entity_type": "Dosage",
          "entity_name": "1",
          "context": "TRI 1"
        }
      ]
    },
    {
      "chunk_id": "db0eb7272230ad64c601ac5fb48e983c",
      "entities": [
        {
          "entity_type": "Compound",
          "entity_name": "citalopram",
          "context": "citalopram significantly down-regulated SERT expression"
        },
        {
          "entity_type": "Effect",
          "entity_name": "down-regulated SERT expression",
          "context": "citalopram significantly down-regulated SERT expression"
        },
        {
          "entity_type": "Effect",
          "entity_name": "down-regulation of SERT",
          "context": "clear down-regulation of SERT"
        },
        {
          "entity_type": "Compound",
          "entity_name": "TRI",
          "context": "higher dose TRI treatment"
        },
        {
          "entity_type": "Dosage",
          "entity_name": "1 mg/ml",
          "context": "1 mg/ml TRI showed results"
        },
        {
          "entity_type": "Compound",
          "entity_name": "TRI",
          "context": "1 mg/ml TRI showed results"
        },
        {
          "entity_type": "Compound",
          "entity_name": "citalopram",
          "context": "comparable to those of the citalopram standard"
        },
        {
          "entity_type": "Dosage",
          "entity_name": "0.1 mg/ml",
          "context": "0.1 mg/ml TRI had effects"
        },
        {
          "entity_type": "Compound",
          "entity_name": "TRI",
          "context": "0.1 mg/ml TRI had effects"
        },
        {
          "entity_type": "Compound",
          "entity_name": "citalopram",
          "context": "similar to that of citalopram"
        },
        {
          "entity_type": "Compound",
          "entity_name": "TRI",
          "context": "effect of TRI on SERT down-regulation"
        },
        {
          "entity_type": "Effect",
          "entity_name": "SERT down-regulation",
          "context": "effect of TRI on SERT down-regulation"
        }
      ]
    },
    {
      "chunk_id": "b17350f636fa6551e4fb688c3a03fd5a",
      "entities": [
        {
          "entity_type": "Compound",
          "entity_name": "mesembrine",
          "context": "high-mesembrine extract"
        },
        {
          "entity_type": "Compound",
          "entity_name": "TRI",
          "context": "TRI acted as modulator"
        },
        {
          "entity_type": "Effect",
          "entity_name": "enzyme inhibition potential",
          "context": "enzyme inhibition potential"
        },
        {
          "entity_type": "Effect",
          "entity_name": "modulator of enzyme function",
          "context": "modulator of enzyme function"
        },
        {
          "entity_type": "Effect",
          "entity_name": "total inhibitor",
          "context": "total inhibitor"
        },
        {
          "entity_type": "Compound",
          "entity_name": "acetylcholine esterase",
          "context": "For acetylcholine esterase (AChE)"
        },
        {
          "entity_type": "Compound",
          "entity_name": "AChE",
          "context": "For acetylcholine esterase (AChE)"
        },
        {
          "entity_type": "Effect",
          "entity_name": "low to moderate inhibition",
          "context": "low to moderate inhibition was evident"
        },
        {
          "entity_type": "Effect",
          "entity_name": "~30% inhibition",
          "context": "only ~30% inhibition was seen"
        },
        {
          "entity_type": "Dosage",
          "entity_name": "2 mg/ml TRI",
          "context": "at a dose of 2 mg/ml TRI"
        },
        {
          "entity_type": "Compound",
          "entity_name": "galanthamine",
          "context": "galanthamine achieved a 30% inhibition"
        },
        {
          "entity_type": "Effect",
          "entity_name": "30% inhibition",
          "context": "galanthamine achieved a 30% inhibition"
        }
      ]
    },
    {
      "chunk_id": "70c89f0f90f569ebfe9c0f3e7431e8ae",
      "entities": [
        {
          "entity_type": "Compound",
          "entity_name": "galantamine",
          "context": "galantamine (solid squares)"
        },
        {
          "entity_type": "Compound",
          "entity_name": "Acetylcholinesterase",
          "context": "Acetylcholinesterase (AChE) inhibition"
        },
        {
          "entity_type": "Compound",
          "entity_name": "mesembrine",
          "context": "high-mesembrine Sceletium extract"
        },
        {
          "entity_type": "Plant",
          "entity_name": "Sceletium",
          "context": "high-mesembrine Sceletium extract"
        },
        {
          "entity_type": "Effect",
          "entity_name": "AChE inhibition",
          "context": "showing AChE inhibition"
        },
        {
          "entity_type": "Effect",
          "entity_name": "% AChE inhibition",
          "context": "% AChE inhibition at extract concentrations"
        },
        {
          "entity_type": "Effect",
          "entity_name": "inhibition",
          "context": "increase in inhibition"
        },
        {
          "entity_type": "Effect",
          "entity_name": "Acetylcholinesterase (AChE) inhibition",
          "context": "Acetylcholinesterase (AChE) inhibition by high-mesembrine Sceletium extract"
        },
        {
          "entity_type": "Dosage",
          "entity_name": "2 mg/ml",
          "context": "concentrations of 2, 0.2, 0.02, and 0.002 mg/ml"
        },
        {
          "entity_type": "Dosage",
          "entity_name": "0.2 mg/ml",
          "context": "concentrations of 2, 0.2, 0.02, and 0.002 mg/ml"
        },
        {
          "entity_type": "Dosage",
          "entity_name": "0.02 mg/ml",
          "context": "concentrations of 2, 0.2, 0.02, and 0.002 mg/ml"
        },
        {
          "entity_type": "Dosage",
          "entity_name": "0.002 mg/ml",
          "context": "concentrations of 2, 0.2, 0.02, and 0.002 mg/ml"
        }
      ]
    },
    {
      "chunk_id": "6ebf5d76301b6ce3c08039a718cd38dc",
      "entities": [
        {
          "entity_type": "Effect",
          "entity_name": "Acetylcholinesterase inhibition",
          "context": "Acetylcholinesterase inhibition induced by high-mesembrine Sceletium extract"
        },
        {
          "entity_type": "Compound",
          "entity_name": "mesembrine",
          "context": "high-mesembrine Sceletium extract"
        },
        {
          "entity_type": "Plant",
          "entity_name": "Sceletium",
          "context": "high-mesembrine Sceletium extract"
        },
        {
          "entity_type": "Compound",
          "entity_name": "galantamine",
          "context": "in comparison to galantamine"
        },
        {
          "entity_type": "Effect",
          "entity_name": "acetylcholinesterase inhibitor",
          "context": "galantamine (acetylcholinesterase inhibitor drug for Alzheimer's disease)"
        },
        {
          "entity_type": "Disease",
          "entity_name": "Alzheimer's disease",
          "context": "drug for Alzheimer's disease"
        },
        {
          "entity_type": "Dosage",
          "entity_name": "12.4 \u00b5g/ml",
          "context": "IC_{50} value for galantamine was 12.4 \\mug/ml"
        }
      ]
    },
    {
      "chunk_id": "d2b389343991690617fbf0ddc5795b61",
      "entities": [
        {
          "entity_type": "Effect",
          "entity_name": "MAO-A inhibition",
          "context": "MAO-A inhibition induced by the extract"
        },
        {
          "entity_type": "Compound",
          "entity_name": "clorgyline",
          "context": "comparison to clorgyline"
        },
        {
          "entity_type": "Effect",
          "entity_name": "irreversible and selective inhibitor of MAO-A",
          "context": "clorgyline (irreversible and selective inhibitor of MAO-A)"
        },
        {
          "entity_type": "Dosage",
          "entity_name": "407.9 \\mug/ml",
          "context": "407.9 \\mug/ml for the extract"
        },
        {
          "entity_type": "Dosage",
          "entity_name": "0.015 \\mug/ml",
          "context": "0.015 \\mug/ml for clorgyline"
        }
      ]
    },
    {
      "chunk_id": "ca0c2dc76876d019bdcb924ba6ef3ff6",
      "entities": [
        {
          "entity_type": "Dosage",
          "entity_name": "0.0025 mg/ml",
          "context": "0.0025 mg/ml"
        },
        {
          "entity_type": "Compound",
          "entity_name": "galanthamine",
          "context": "galanthamine"
        },
        {
          "entity_type": "Dosage",
          "entity_name": "12.4 \u00b5g/ml",
          "context": "12.4 \u00b5g/ml"
        },
        {
          "entity_type": "Compound",
          "entity_name": "TRI",
          "context": "TRI"
        }
      ]
    },
    {
      "chunk_id": "3ed20463c6f9b261ea91e84d887e4633",
      "entities": [
        {
          "entity_type": "Effect",
          "entity_name": "mild SSRI activity",
          "context": "despite its mild SSRI activity"
        },
        {
          "entity_type": "Compound",
          "entity_name": "cocaine",
          "context": "such as cocaine"
        },
        {
          "entity_type": "Compound",
          "entity_name": "sertraline",
          "context": "and sertraline"
        },
        {
          "entity_type": "Effect",
          "entity_name": "SSRI",
          "context": "function as SSRI"
        },
        {
          "entity_type": "Compound",
          "entity_name": "SERT",
          "context": "blocking of SERT"
        },
        {
          "entity_type": "Compound",
          "entity_name": "amphetamine",
          "context": "such as amphetamine"
        },
        {
          "entity_type": "Compound",
          "entity_name": "methamphetamine",
          "context": "and methamphetamine"
        },
        {
          "entity_type": "Effect",
          "entity_name": "addictive effect",
          "context": "the addictive (award) effect"
        },
        {
          "entity_type": "Compound",
          "entity_name": "cocaine",
          "context": "effect of cocaine"
        },
        {
          "entity_type": "Compound",
          "entity_name": "SERT",
          "context": "inhibition of both SERT"
        },
        {
          "entity_type": "Compound",
          "entity_name": "dopamine transporter",
          "context": "and dopamine transporter (DAT)"
        },
        {
          "entity_type": "Compound",
          "entity_name": "DAT",
          "context": "dopamine transporter (DAT)"
        },
        {
          "entity_type": "Effect",
          "entity_name": "withdrawal symptoms",
          "context": "the withdrawal symptoms"
        },
        {
          "entity_type": "Compound",
          "entity_name": "cocaine",
          "context": "after cocaine or alcohol abuse"
        },
        {
          "entity_type": "Compound",
          "entity_name": "alcohol",
          "context": "or alcohol abuse"
        },
        {
          "entity_type": "Plant",
          "entity_name": "Sceletium sp.",
          "context": "another Sceletium extract"
        },
        {
          "entity_type": "Compound",
          "entity_name": "mesembrine",
          "context": "alkaloids mesembrine"
        },
        {
          "entity_type": "Compound",
          "entity_name": "mesembrenone",
          "context": "mesembrenone"
        },
        {
          "entity_type": "Compound",
          "entity_name": "mesembrenol",
          "context": "and mesembrenol"
        },
        {
          "entity_type": "Effect",
          "entity_name": "inhibition of dopamine transporters",
          "context": "no significant inhibition of dopamine transporters"
        },
        {
          "entity_type": "Compound",
          "entity_name": "mesembrine",
          "context": "high-mesembrine Sceletium products"
        },
        {
          "entity_type": "Plant",
          "entity_name": "Sceletium sp.",
          "context": "high-mesembrine Sceletium products"
        },
        {
          "entity_type": "Disease",
          "entity_name": "cocaine addiction",
          "context": "treatment of cocaine addiction"
        },
        {
          "entity_type": "Compound",
          "entity_name": "TRI",
          "context": "ability of TRI"
        },
        {
          "entity_type": "Compound",
          "entity_name": "VMAT-2",
          "context": "up-regulate VMAT-2"
        },
        {
          "entity_type": "Disease",
          "entity_name": "neuronal dopamine abnormalities",
          "context": "involve neuronal dopamine abnormalities"
        },
        {
          "entity_type": "Disease",
          "entity_name": "Parkinson's disease",
          "context": "such as Parkinson's disease"
        },
        {
          "entity_type": "Compound",
          "entity_name": "VMAT-2",
          "context": "modulation of VMAT-2"
        },
        {
          "entity_type": "Disease",
          "entity_name": "cocaine addiction",
          "context": "cocaine and alcohol addiction"
        },
        {
          "entity_type": "Disease",
          "entity_name": "alcohol addiction",
          "context": "and alcohol addiction"
        },
        {
          "entity_type": "Disease",
          "entity_name": "Parkinson's disease",
          "context": "also Parkinson's disease"
        }
      ]
    },
    {
      "chunk_id": "bdfc4cc5ef861c54e1286e37c0dbb93d",
      "entities": [
        {
          "entity_type": "Compound",
          "entity_name": "mesembrine",
          "context": "high-mesembrine Sceletium"
        },
        {
          "entity_type": "Plant",
          "entity_name": "Sceletium",
          "context": "high-mesembrine Sceletium"
        },
        {
          "entity_type": "Effect",
          "entity_name": "monoamine releasing agent",
          "context": "potential as monoamine releasing agent"
        },
        {
          "entity_type": "Compound",
          "entity_name": "monoamine oxidase type A (MAO-A)",
          "context": "inhibition of monoamine oxidase type A (MAO-A) activity"
        },
        {
          "entity_type": "Effect",
          "entity_name": "mild inhibition",
          "context": "showed only a mild inhibition of monoamine oxidase type A (MAO-A) activity"
        },
        {
          "entity_type": "Compound",
          "entity_name": "MAO-A",
          "context": "MAO-A plays an important role"
        },
        {
          "entity_type": "Effect",
          "entity_name": "metabolism",
          "context": "metabolism of intracellular neurotransmitters"
        },
        {
          "entity_type": "Compound",
          "entity_name": "neurotransmitters",
          "context": "metabolism of intracellular neurotransmitters"
        },
        {
          "entity_type": "Disease",
          "entity_name": "depression",
          "context": "context of especially depression"
        },
        {
          "entity_type": "Effect",
          "entity_name": "MAO-A inhibition",
          "context": "MAO-A inhibition \u2013 which results in less intracellular monoamine breakdown"
        },
        {
          "entity_type": "Effect",
          "entity_name": "less intracellular monoamine breakdown",
          "context": "results in less intracellular monoamine breakdown"
        },
        {
          "entity_type": "Compound",
          "entity_name": "monoamine",
          "context": "less intracellular monoamine breakdown"
        },
        {
          "entity_type": "Disease",
          "entity_name": "neurodegenerative disorders",
          "context": "treatment of neurodegenerative disorders"
        },
        {
          "entity_type": "Disease",
          "entity_name": "Alzheimer's",
          "context": "Alzheimer's and Parkinson's disease"
        },
        {
          "entity_type": "Disease",
          "entity_name": "Parkinson's disease",
          "context": "Alzheimer's and Parkinson's disease"
        },
        {
          "entity_type": "Compound",
          "entity_name": "MAO-A",
          "context": "downregulation of MAO-A by methamphetamine"
        },
        {
          "entity_type": "Compound",
          "entity_name": "methamphetamine",
          "context": "downregulation of MAO-A by methamphetamine"
        },
        {
          "entity_type": "Effect",
          "entity_name": "downregulation",
          "context": "excessive downregulation of MAO-A"
        },
        {
          "entity_type": "Effect",
          "entity_name": "chronic pulmonary toxicity",
          "context": "linked to chronic pulmonary toxicity"
        },
        {
          "entity_type": "Compound",
          "entity_name": "MAO inhibitors",
          "context": "use of MAO inhibitors"
        },
        {
          "entity_type": "Compound",
          "entity_name": "monoamine",
          "context": "monoamine releasing agents such as MDMA"
        },
        {
          "entity_type": "Compound",
          "entity_name": "MDMA",
          "context": "monoamine releasing agents such as MDMA"
        },
        {
          "entity_type": "Effect",
          "entity_name": "low level inhibition",
          "context": "low level inhibition reported here"
        },
        {
          "entity_type": "Compound",
          "entity_name": "MAO inhibitors",
          "context": "MAO inhibitors are known to inhibit the P450 enzymes"
        },
        {
          "entity_type": "Effect",
          "entity_name": "inhibit",
          "context": "known to inhibit the P450 enzymes"
        },
        {
          "entity_type": "Compound",
          "entity_name": "P450 enzymes",
          "context": "inhibit the P450 enzymes"
        },
        {
          "entity_type": "Effect",
          "entity_name": "targeted inhibition",
          "context": "targeted inhibition of specific P450 enzymes"
        },
        {
          "entity_type": "Compound",
          "entity_name": "TRI",
          "context": "specific P450 enzymes by high-dose TRI"
        },
        {
          "entity_type": "Dosage",
          "entity_name": "high-dose",
          "context": "by high-dose TRI"
        },
        {
          "entity_type": "Compound",
          "entity_name": "steroid",
          "context": "context of steroid synthesis"
        },
        {
          "entity_type": "Effect",
          "entity_name": "steroid synthesis",
          "context": "context of steroid synthesis"
        },
        {
          "entity_type": "Compound",
          "entity_name": "TRI",
          "context": "TRI also alleviated"
        },
        {
          "entity_type": "Effect",
          "entity_name": "alleviated",
          "context": "TRI also alleviated forskolin- and angiotensin II-induced aldosterone synthesis"
        },
        {
          "entity_type": "Compound",
          "entity_name": "forskolin",
          "context": "alleviated forskolin- and angiotensin II-induced aldosterone synthesis"
        },
        {
          "entity_type": "Compound",
          "entity_name": "angiotensin II",
          "context": "forskolin- and angiotensin II-induced aldosterone synthesis"
        },
        {
          "entity_type": "Compound",
          "entity_name": "aldosterone",
          "context": "aldosterone synthesis"
        },
        {
          "entity_type": "Effect",
          "entity_name": "aldosterone synthesis",
          "context": "aldosterone synthesis"
        },
        {
          "entity_type": "Effect",
          "entity_name": "anti-hypertension effect",
          "context": "suggesting an anti-hypertension effect"
        },
        {
          "entity_type": "Dosage",
          "entity_name": "high dose",
          "context": "at high dose only"
        },
        {
          "entity_type": "Effect",
          "entity_name": "mild MAO-A inhibition",
          "context": "only mild MAO-A inhibition"
        },
        {
          "entity_type": "Compound",
          "entity_name": "MAO-A",
          "context": "only mild MAO-A inhibition"
        },
        {
          "entity_type": "Effect",
          "entity_name": "mild inhibition",
          "context": "relatively mild inhibition of MAO-A"
        },
        {
          "entity_type": "Compound",
          "entity_name": "MAO-A",
          "context": "mild inhibition of MAO-A"
        },
        {
          "entity_type": "Effect",
          "entity_name": "cytotoxicity",
          "context": "not cause cytotoxicity"
        },
        {
          "entity_type": "Dosage",
          "entity_name": "large doses",
          "context": "even at large doses"
        },
        {
          "entity_type": "Effect",
          "entity_name": "counter-medication",
          "context": "employed as counter-medication"
        },
        {
          "entity_type": "Disease",
          "entity_name": "addiction",
          "context": "counter-medication in addiction"
        }
      ]
    },
    {
      "chunk_id": "45e503f85c29a70aa488abc1aa0041e2",
      "entities": [
        {
          "entity_type": "Compound",
          "entity_name": "MAO-A",
          "context": "As for MAO-A, our data indicates"
        },
        {
          "entity_type": "Compound",
          "entity_name": "acetylcholinesterase (AChE)",
          "context": "inhibition of acetylcholinesterase (AChE) activity"
        },
        {
          "entity_type": "Compound",
          "entity_name": "TRI",
          "context": "activity by TRI."
        },
        {
          "entity_type": "Effect",
          "entity_name": "mild inhibition of acetylcholinesterase (AChE) activity",
          "context": "a rather mild inhibition of acetylcholinesterase (AChE) activity"
        },
        {
          "entity_type": "Plant",
          "entity_name": "Sceletium",
          "context": "report on Sceletium extract"
        },
        {
          "entity_type": "Dosage",
          "entity_name": "1 mg/ml",
          "context": "in which 1 mg/ml of pure mesembrine"
        },
        {
          "entity_type": "Compound",
          "entity_name": "mesembrine",
          "context": "pure mesembrine achieved only a \u2248 30% AChE inhibition"
        },
        {
          "entity_type": "Effect",
          "entity_name": "\u2248 30% AChE inhibition",
          "context": "achieved only a \u2248 30% AChE inhibition"
        },
        {
          "entity_type": "Plant",
          "entity_name": "Sceletium tortuosum",
          "context": "alkaloid extract from Sceletium tortuosum"
        },
        {
          "entity_type": "Effect",
          "entity_name": "inhibited AChE in a dose-dependent manner",
          "context": "inhibited AChE in a dose-dependent manner"
        },
        {
          "entity_type": "Dosage",
          "entity_name": "1 mg/ml",
          "context": "assessed (1 mg/ml) resulting in 87% inhibition"
        },
        {
          "entity_type": "Effect",
          "entity_name": "87% inhibition",
          "context": "resulting in 87% inhibition"
        },
        {
          "entity_type": "Effect",
          "entity_name": "inhibitory effects on AChE activity",
          "context": "plant's inhibitory effects on AChE activity"
        },
        {
          "entity_type": "Compound",
          "entity_name": "mesembrine",
          "context": "low mesembrine content was reported"
        },
        {
          "entity_type": "Effect",
          "entity_name": "inhibit acetylcholinesterase activity by 7%",
          "context": "only inhibit acetylcholinesterase activity by 7%"
        },
        {
          "entity_type": "Compound",
          "entity_name": "alkaloids",
          "context": "extract and alkaloids, which may have been too low"
        },
        {
          "entity_type": "Effect",
          "entity_name": "therapeutic effect",
          "context": "achieve therapeutic effect in this context"
        },
        {
          "entity_type": "Plant",
          "entity_name": "Sceletium",
          "context": "indigenous use of Sceletium"
        },
        {
          "entity_type": "Effect",
          "entity_name": "inhibitory effect",
          "context": "may well have an inhibitory effect"
        }
      ]
    },
    {
      "chunk_id": "036089bf1e209f301d5c2a14cf49f2a8",
      "entities": [
        {
          "entity_type": "Compound",
          "entity_name": "acetylcholinesterase",
          "context": "on acetylcholinesterase activity"
        },
        {
          "entity_type": "Compound",
          "entity_name": "mesembrine",
          "context": "high mesembrine content"
        },
        {
          "entity_type": "Effect",
          "entity_name": "inhibitory capacity",
          "context": "lost this inhibitory capacity"
        },
        {
          "entity_type": "Effect",
          "entity_name": "potentiation",
          "context": "loss of potentiation"
        },
        {
          "entity_type": "Compound",
          "entity_name": "alkaloids",
          "context": "other minor alkaloids"
        }
      ]
    },
    {
      "chunk_id": "85b1a63524666ad7497b457088f194fe",
      "entities": [
        {
          "entity_type": "Compound",
          "entity_name": "mesembrine",
          "context": "high-mesembrine Sceletium extract"
        },
        {
          "entity_type": "Plant",
          "entity_name": "Sceletium",
          "context": "high-mesembrine Sceletium extract"
        },
        {
          "entity_type": "Effect",
          "entity_name": "anti-depressant effect",
          "context": "exerts its anti-depressant effect"
        },
        {
          "entity_type": "Effect",
          "entity_name": "monoamine releasing agent",
          "context": "acting primarily as monoamine releasing agent"
        },
        {
          "entity_type": "Effect",
          "entity_name": "selective serotonin-reuptake inhibitor",
          "context": "rather than as selective serotonin-reuptake inhibitor"
        },
        {
          "entity_type": "Effect",
          "entity_name": "Enzyme inhibition",
          "context": "Enzyme inhibition data suggests"
        },
        {
          "entity_type": "Effect",
          "entity_name": "low risk for toxicity",
          "context": "may have low risk for toxicity"
        },
        {
          "entity_type": "Effect",
          "entity_name": "mild modulator",
          "context": "potential as mild modulator"
        },
        {
          "entity_type": "Disease",
          "entity_name": "attention deficit disorders",
          "context": "conditions such as attention deficit disorders"
        },
        {
          "entity_type": "Disease",
          "entity_name": "Alzheimer's disease",
          "context": "and Alzheimer's disease"
        }
      ]
    }
  ],
  "total_entities": 265,
  "extraction_date": "2026-02-01T08:37:30.779328+00:00"
}